Dr. Jane M. Liebschutz, MD

Dr. Liebschutz practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Liebschutz's NPI, 1679501548, was assigned on June 29, 2006. Dr. Liebschutz graduated from Harvard Medical School in 1991. Dr. Liebschutz holds Pennsylvania license 462178.

Dr. Liebschutz's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Dr. Liebschutz's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Liebschutz is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Liebschutz to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Liebschutz practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Liebschutz's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Liebschutz is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Liebschutz's licenses on file in 2 states: Pennsylvania and Massachusetts.

Dmand AI lists arthritis, chronic diabetes, chronic hypertension, chronic indigestion, chronic inflammatory bowel disease (IBD), chronic kidney disease, depression and drug use disorders among the conditions Dr. Liebschutz treats.

CMS data shows 26 Medicare services from Dr. Liebschutz across 1 procedure code in 2024, all of them office visits, for 23 Medicare patients. Medicare paid $1,681 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 23 Medicare patients who saw Dr. Liebschutz in 2024. 74% of them have high blood pressure, and 57% have high cholesterol. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Liebschutz's median patient age at 65, with 62% women.

In 2024, Dr. Liebschutz wrote 1,303 Medicare Part D claims for 65 patients. 90% of them were for generic drugs. CMS names the drug for 871 of them, across 34 drugs with 11 or more claims each, at $87,182 in total drug cost. In 2023, CMS named 651 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Liebschutz for performance year 2024, reported as part of a group. Dr. Liebschutz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Liebschutz as offering telehealth.

Dmand AI links 199 papers to Dr. Liebschutz, published from 2006 to 2025. 2021 was the busiest year, with 19. The most frequent topics are Analgesics, Opioid, Opioid-Related Disorders and Chronic Pain. Dr. Liebschutz has published most often in J Gen Intern Med. Dr. Liebschutz's most frequent co-authors are Judith Ihseen Tsui, MD, Joanna L. Starrels, MD, MS and Jonathan Arthur Colasanti, MD.

Dmand AI links Dr. Liebschutz to 2 clinical trials. Conditions studied include Bacterial Infections, Opioid-Related Disorders and Bacterial Infections and Mycoses.

CMS Open Payments shows 1 general payment to Dr. Liebschutz from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Indivior Inc. paid the most, $23.

Dmand AI lists 9 awards for Dr. Liebschutz, most recently NCQA PCMH in 2016.

Dr. Liebschutz graduated from Harvard Medical School in 1991. Dr. Liebschutz is a member of SGIM.

Dr. Liebschutz is in network with 14 carriers, including Elevance, Highmark and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.